share_log

AbbVie | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)

SEC announcement ·  May 17 21:07
Summary by Futu AI
The New York Stock Exchange (NYSE) has officially notified the Securities and Exchange Commission (SEC) of its intention to delist the entire class of securities of GRI BIO, Inc. This action is set to take place at the start of business on May 28, 2024, in accordance with Rule 12d2-2(a). The notification follows the redemption or full payment of the securities at maturity or retirement, which occurred on May 17, 2024. Consequently, trading of GRI BIO, Inc.'s securities was suspended on the NYSE as of May 17, 2024.
The New York Stock Exchange (NYSE) has officially notified the Securities and Exchange Commission (SEC) of its intention to delist the entire class of securities of GRI BIO, Inc. This action is set to take place at the start of business on May 28, 2024, in accordance with Rule 12d2-2(a). The notification follows the redemption or full payment of the securities at maturity or retirement, which occurred on May 17, 2024. Consequently, trading of GRI BIO, Inc.'s securities was suspended on the NYSE as of May 17, 2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.